摘要:
Ethylene copolymers or terpolymers containing repeating units derived from ethylenically unsaturated carboxylic acids which have been surface treated with from 0.005 to 2 wt. % silica to reduce surface tackiness are disclosed.
摘要:
The viscosity stability of a copolymer of ethylene with at least one comonomer which is an ethylenically unsaturated carboxylic acid is improved by exposing the isolated copolymer to moisture for a sufficient period to cause the copolymer to retain at least 20 weight percent more water than it would retain if it were purged with air or nitrogen heated to a temperature at least 5.degree. C. above ambient, which air or nitrogen has not been humidified after it has been heated to such temperature.
摘要:
Highly flexible articles having wall thickness of at least 0.01 inches are made from chlorine-free direct ethylene copolymers containing small amounts of selected known slip additives. Articles in the form of tubes or tubing have particular utility for replacement of PVC based tubing used in medical applications.
摘要:
Recombinant plasminogen activator inhibitor-1 (PAI-1) isoforms which lack the reactive center loop and contain the complete heparin-binding domain or lack at least a portion of the heparin-binding domain are described. The rPAI-1 isoforms disclosed herein may be used to modulate angiogenesis through blocking release of VEGF from a VEGF-heparin complex. Furthermore, the rPAI-1 proteins may be used to inhibit cell proliferation and migration, induce apoptosis, and produce proteolytic fragments corresponding to angiostatin kringles 1-3 and kringles 1-4. A truncated proteolytic plasmin protein of 34 kDa is also provided.
摘要:
Recombinant plasminogen activator inhibitor-1 (PAI-1) isoforms which lack the reactive center loop and contain the complete heparin-binding domain or lack at least a portion of the heparin-binding domain are described. The rPAI-1 isoforms disclosed herein may be used to modulate angiogenesis through blocking release of VEGF from a VEGF-heparin complex. Furthermore the rPAI-1 proteins may be used to inhibit cell proliferation and migration, induce apoptosis, and produce proteolytic fragments corresponding to angiostatin kringles 1–3 and kringles 1–4.